Correlation Between Mineralys Therapeutics, and Protagenic Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Protagenic Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Protagenic Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and Protagenic Therapeutics
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Mineralys and Protagenic is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Protagenic Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Protagenic Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.09 times more return on investment than Protagenic Therapeutics. However, Mineralys Therapeutics, is 1.09 times more volatile than Protagenic Therapeutics. It trades about -0.06 of its potential returns per unit of risk. Protagenic Therapeutics is currently generating about -0.45 per unit of risk. If you would invest 1,389 in Mineralys Therapeutics, Common on August 29, 2024 and sell it today you would lose (137.00) from holding Mineralys Therapeutics, Common or give up 9.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 22.73% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Protagenic Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Protagenic Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
Mineralys Therapeutics, and Protagenic Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Protagenic Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals | Mineralys Therapeutics, vs. Seres Therapeutics |
| Protagenic Therapeutics vs. Eliem Therapeutics | Protagenic Therapeutics vs. Scpharmaceuticals | Protagenic Therapeutics vs. Milestone Pharmaceuticals | Protagenic Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |